Company intelligence / Profile preview
Kalm Therapeutics
Huntsville, Alabama, United Stateskalmtherapeutics.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Developing the first prescription patch treatment for eczema and psoriasis. Completed Pre-IND meeting with FDA and preparing for IND submission in 2025.
- Therapeutic areas
- Dermatology
- Modalities
- Small moleculescontrolled-release patch
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
CFD ResearchSouthern Research
Beyond the preview
Go deeper on Kalm Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kalm Therapeutics.